Reviva Pharmaceuticals Holdings Stock Today
| RVPHW Stock | USD 0.21 0.04 23.53% |
Performance11 of 100
| Odds Of DistressOver 67
|
Reviva Pharmaceuticals is selling for under 0.21 as of the 24th of November 2024; that is 23.53 percent increase since the beginning of the trading day. The stock's lowest day price was 0.21. Reviva Pharmaceuticals has more than 67 % chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. Equity ratings for Reviva Pharmaceuticals Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of November 2023 and ending today, the 24th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 18th of October 2018 | Category Healthcare | Classification Health Care |
Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. More on Reviva Pharmaceuticals Holdings
Moving against Reviva Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Reviva Stock Highlights
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Materials, Materials (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Reviva Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Reviva Pharmaceuticals' financial leverage. It provides some insight into what part of Reviva Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Reviva Pharmaceuticals Holdings (RVPHW) is traded on NASDAQ Exchange in USA. It is located in 10080 N. Wolfe Road, Cupertino, CA, United States, 95014 and employs 15 people. Reviva Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.81 M. Reviva Pharmaceuticals classifies itself under Pharmaceuticals sector and is part of Health Care industry.
Reviva Pharmaceuticals Holdings has accumulated about 353.26 K in cash with (28.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Reviva Pharmaceuticals Probability Of Bankruptcy
Reviva Pharmaceuticals Historical Income Statement
Reviva Stock Against Markets
Additional Tools for Reviva Stock Analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.